Asuragen, Inc. is a leading provider of innovative genetic testing solutions and precision oncology solutions based in Austin, TX. They offer a comprehensive portfolio of assay kits for inherited genetic disorders, such as fragile X syndrome, CFTR, and SMN1 2, as well as solutions for complex molecular challenges in oncology, including chronic myeloid leukemia (CML) and solid tumors. With a focus on delivering better answers, Asuragen's products are designed to provide accurate and reliable results, enabling healthcare professionals to make informed decisions for their patients.
With a commitment to advancing molecular diagnostics, Asuragen also offers molecular quality controls, custom assay development services, and companion diagnostics. Their expertise in assay chemistries, bioinformatics, and product development processes ensures the development of high-quality and reliable testing solutions. Asuragen's dedication to innovation and their collaborative approach with partners and customers make them a trusted leader in the field of genetic testing and precision oncology.
Generated from the website